2025 年 7 月 1 日,Teleflex宣布已提前完成对 Biotronik 血管介入(Vascular Intervention, VI)业务的收购。此次收购为总部位于宾夕法尼亚州韦恩的Teleflex的介入通路产品组合增添了广泛的治疗性产品。Teleflex表示,新业务还将有助于该公司在快速增长的外周介入市场建立影响力。该VI业务的主要产品包括Orsiro药物洗脱支架、Pantera ...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.